您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > HB007
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
HB007
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
HB007图片
规格:98%
分子量:328.78
包装与价格:
包装价格(元)
5mg电议
10mg电议
25mg电议
50mg电议

产品介绍
HB007 是一种小的泛素相关修饰剂 1 (SUMO1) 降解剂。HB007 诱导 SUMO1 的泛素化和降解,导致体内肿瘤生长减少。HB007 可用于脑癌、乳腺癌、结肠癌和肺癌的研究。
货号:ajcx34830
CAS:2387821-46-5
分子式:C15H9ClN4OS
分子量:328.78
溶解度:N/A
纯度:98%
存储:Store at -20°C
库存:现货

Background:

HB007 is a small ubiquitin-related modifier 1 (SUMO1) degrader. HB007 induces ubiquitination and degradation of SUMO1, resulting in reduced tumor growth in vivo. HB007 can be used for the research of brain, breast, colon, and lung cancers[1][2].

HB007 (compound 24) (0.1-100 μM) inhibits LN229 cell growth in a concentration-dependent manner t[1].HB007 (10-25 μM) reduces SUM01 conjugation and total protein levels of SUM01 but not SUM02/3 or UB in LN229 cells t[1].

HB007 (compound 24) (25-50 mg/kg; i.p. for 15 d) significantly suppresses tumor growth of colon and lung cancer but had no effect on the body weights of mice[1].

[1]. Bellail AC, et, al. Ubiquitination and degradation of SUMO1 by small-molecule degraders extends survival of mice with patient-derived tumors. Sci Transl Med. 2021 Oct 13;13(615):eabh1486.
[2]. BELLAIL A, et, al. Compositions and methods for treating cancer. WO2019217509A1.